🔎 Trials Near Me

Utama › Penyakit Sel Sabit › Tennessee

Kajian klinikal Penyakit Sel Sabit di Tennessee

22 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi di Tennessee.

Bandar di Tennessee

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • University of Tennessee Health Science Center, Memphis
  • St. Jude Children's Res Hosp, Memphis
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06612268

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Umur 8 hingga 17 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07226219

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06442761

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • St. Jude Children's Research Hospital, Memphis
  • Vanderbilt University Medical Center, Nashville
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628

Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 8 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT05810181

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Vanderbilt University Medical Center, Nashville
Mengambil pesertaKajian pemerhatian
Umur 4 hingga 65 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05153967

Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

  • St Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 2
Sehingga umur 22 · Semua jantina · Dikemas kini 23 Jul 2026 · NCT07616154

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 25 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06477289

Investigation of the Genetics of Hematologic Diseases

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 9 Jun 2026 · NCT02720679

Sickle Cell Clinical Research and Intervention Program

  • Regional One Health, Diggs-Kraus Sickle Cell Center, Memphis
  • Methodist Adult Comprehensive Sickle Cell Center, Memphis
  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 4 Jun 2026 · NCT02098863

Functional Ovarian Reserve in Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 10 hingga 18 · Wanita · Dikemas kini 4 Jun 2026 · NCT07392216

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • St Jude Children Hospital (NT-DMT), Memphis
  • St. Jude Children's Research Hospital (MRD-HCT), Memphis
Mengambil pesertaKajian pemerhatian
Umur 3 hingga 20 · Semua jantina · Dikemas kini 4 Jun 2026 · NCT06941389

Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Mengambil peserta
Umur 6 hingga 25 · Semua jantina · Dikemas kini 18 Mei 2026 · NCT03353584

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 18 hingga 21 · Semua jantina · Dikemas kini 6 Mei 2026 · NCT05583721

Gene Editing For Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Umur 18 hingga 24 · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06506461

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

  • St. Jude Children's Research Hospital, Memphis
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 13 ke atas · Semua jantina · Dikemas kini 1 Mei 2026 · NCT04416178

School Readiness Intervention for Preschool Children With Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Mengambil peserta
42 Months – 78 Months · Semua jantina · Dikemas kini 24 Apr 2026 · NCT06367192

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

  • Vanderbilt University, Nashville
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Mac 2026 · NCT06919224

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

  • TriStar Medical Group Children's Specialists - Pediatric Oncology, Nashville
Mengambil pesertaFasa 3
Umur 12 hingga 35 · Semua jantina · Dikemas kini 23 Mac 2026 · NCT05477563

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • St. Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
Mengambil pesertaKajian pemerhatian
Umur 14 hingga 37 · Semua jantina · Dikemas kini 28 Jan 2026 · NCT07373639

HPC Offered for PRESERVE Expansion

  • Tristar Centennial Medical Center, Nashville
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 80 · Semua jantina · Dikemas kini 28 Ogo 2025 · NCT07145411

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Tennessee at Memphis, Memphis
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jun 2025 · NCT06385886

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.